Cargando...
Renal tuberculosis in an imatinib-treated chronic myeloid leukemia
Imatinib, which inhibits tyrosine kinase activity of Bcr-Abl protein, is a standard form of treatment for chronic myeloid leukemia (CML). Through its immunomodulatory effect it affects T cell function in a number of ways. It inhibits antigen-induced T cell activation and proliferation. Antigen-speci...
Guardado en:
| Publicado en: | J Bras Nefrol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Sociedade Brasileira de Nefrologia
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7657051/ https://ncbi.nlm.nih.gov/pubmed/32353102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/2175-8239-JBN-2019-0123 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|